Duquesne Family Office - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 200 filers reported holding NEKTAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
Duquesne Family Office ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2021$17,960,000
+4.7%
1,000,0000.0%0.58%
+37.2%
Q2 2021$17,160,000
-14.2%
1,000,0000.0%0.42%
-3.6%
Q1 2021$20,000,000
+198.3%
1,000,000
+222.0%
0.44%
+123.9%
Q4 2019$6,704,000
-94.7%
310,579
-74.0%
0.20%
-97.2%
Q1 2018$126,694,000
+15.7%
1,192,300
-35.0%
7.00%
+26.8%
Q4 2017$109,526,000
+291.4%
1,834,000
+57.3%
5.52%
+333.7%
Q3 2017$27,986,000
+22.8%
1,166,1000.0%1.27%
+4.3%
Q2 2017$22,797,000
+45.9%
1,166,100
+75.2%
1.22%
+19.1%
Q1 2017$15,622,000
+58.9%
665,600
+16.3%
1.02%
+18.0%
Q3 2016$9,829,000
+36.4%
572,100
-12.7%
0.87%
-5.1%
Q1 2015$7,205,000
-29.0%
655,0000.0%0.92%
-7.9%
Q4 2014$10,153,000655,0001.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2017
NameSharesValueWeighting ↓
Monaco Asset Management SAM 4,809,601$2,864,5980.85%
Lynx1 Capital Management LP 1,766,815$1,052,3150.70%
CM Management, LLC 800,000$476,4800.51%
Deep Track Capital, LP 18,400,000$10,959,0400.42%
TANG CAPITAL MANAGEMENT LLC 3,939,600$2,346,4260.33%
Acuitas Investments, LLC 721,460$429,7020.25%
RA Capital Management 18,700,000$11,137,7200.22%
GSA CAPITAL PARTNERS LLP 1,841,078$1,0970.09%
UBS OCONNOR LLC 1,376,249$820,2440.02%
Marquette Asset Management, LLC 148,378$88,3740.02%
View complete list of NEKTAR THERAPEUTICS shareholders